SCHEMBL6352806

SCHEMBL6352806

O=C(Nc1ccc(Br)cc1C(=O)O)c1ccc(S(=O)(=O)NCc2ccccc2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.61
KMT2A Q03164 3/20 0.61
ALDH1A1 P00352 2/20 0.61
KDM4E B2RXH2 1/20 0.56
OPRK1 P41145 3/20 0.54
MAPT P10636 4/20 0.53
AKR1C4 P17516 1/20 0.53
AKR1C3 P42330 1/20 0.53
AKR1C2 P52895 1/20 0.53
AKR1C1 Q04828 1/20 0.53
TP53 P04637 3/20 0.53
CCR8 P51685 1/20 0.52
KCNK2 O95069 1/20 0.51
KCNK10 P57789 1/20 0.51
OPRM1 P35372 2/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
LTC4S Q16873 1/20 0.50
CYP19A1 P11511 1/20 0.50
CA12 O43570 1/20 0.50
CA9 Q16790 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6352089 0.88 TP53 (0.49) MEN1KMT2AALDH1A1KDM4EOPRK1
SCHEMBL6349137 0.87 MEN1 (0.47) MEN1KMT2AALDH1A1KDM4EOPRK1
SCHEMBL6359773 0.85 MEN1 (0.64) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL6350610 0.81 MEN1 (0.69) MEN1KMT2AMAPTAKR1C4AKR1C3
SCHEMBL6834204 0.81 KMT2A (0.51) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL6358636 0.81 PRMT1 (0.50) MEN1KMT2AKDM4EMAPTAKR1C4
SCHEMBL6346641 0.80 METAP2 (0.58) MEN1KMT2AMAPTAKR1C4AKR1C3
SCHEMBL6352275 0.80 AKR1C2 (0.53) MEN1KMT2AALDH1A1KDM4EMAPT
SCHEMBL9513479 0.79 MAPT (0.80) MEN1KMT2AMAPTAKR1C4AKR1C3
SCHEMBL17166275 0.79 AKR1C2 (0.73) MEN1KMT2AALDH1A1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113450-A1 Antibacterial agents PHARMACIA & UPJOHN COMPANY 2005-05-26 US claimed
US-20050113450-A1 Antibacterial agents PHARMACIA & UPJOHN COMPANY 2005-05-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113450-A1 Antibacterial agents CLPP, SPOUT1, SAMHD1 MEN1 3274/4885KMT2A 3645/4885ALDH1A1 462/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.